Oct 14, 2025 17:46
IMA - ImageneBio, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 7.17 0.1 (1.39%) | 0.0 (0.0%) | 0.0 (0.0%) | -0.01 (-0.14%) | --- | 0.1 (1.39%) | --- | --- |
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- -0.1
- Diluted EPS:
- -0.1
- Basic P/E:
- -72.7
- Diluted P/E:
- -72.7
- RSI(14) 1m:
- 25.0
- VWAP:
- 7.27
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|